Dako and Cytomation join operations
This article was originally published in Clinica
Danish diagnostic company Dako is to combine operations with Cytomation, of Fort Collins, Colorado. The deal brings together Cytomation's bioinstrumentation and software with Dako's biotech and diagnostic experience. The unit will be headed by Copenhagen-based Dako's president and CEO, Jes Estergaard, while Nigel Ferrey, Cytomation's president and CEO, will be responsible for US operations. He will also join the corporate management group.
You may also be interested in...
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
HBW Market News: FTC Ends Another Supplement Scam, Australia Win For ChromaDex, GOED Report, Herbalife
Herbalife opens 9,200 square-foot training facility in China; GOED's latest annual market report, covering 2017-2018, is available; ChromaDex has two-tear exclusivity for nicotinamide riboside chloride in Australia; and A.S. Research arthritis claims for Synovia end in FTC settlement.
Pharma sells the rights to Germany’s Cheplapharm, which obtained EU/Russia rights in October. Cerecor will acquire Aevi Genomics for $16.1m plus contingent value rights.